Reputation, Competitors, & Current state of Philips Healthcare

in talks with Philips Healthcare for a sales position. (Patient monitoring supplies) Any information that you can provide on the reputation in the field for this division and market share for these products would be greatly appreciated.

I am very interested in hearing about the current climate working for Philips in sales. I've heard some really good things and I am just starting out in my career. Is this a solid company with potential to grow and a good name on the resume for medical sales? It's my understanding there is a lot of longevity here and once your in and hit your numbers its a decent company to be at.

All feedback is appreciated and thanks in advance!

 

Ha!

 

RUN!!!!!!
Multiple sales people laid off last month and looking to have a few hundred field people either this month or next month. Engineer morale is extremely low and will get lower after the layoffs. A large portion of the senior engineers will leave early next year bc of the pension dropoff

 

GTM strategy failed. Lots of turnover. Latest management ploy : hiring B or C level players with unreasonable OP to milk the sales that have been help up due to FDA issues and problems with some of the newly release ( AKA warmed up old products ) was once a great organization, no longer.
Compensation has been managed down by about $40k per year -even at plan . time to retire

 

Dutch electronics and health care giant Philips remains in ill health
Dutch electronics and health care giant Philips, which has had major problems at its Highland Heights manufacturing plant, remains in ill health.

So says The Wall Street Journal, which looks at the state of Philips in the wake of the company’s plan to spend $1.2 billion to buy Volcano Corp., which makes imaging catheters used to look inside organs. The company’s health care revenues would immediately increase by 3.5%, “and Volcano should return a positive operating income by 2015 and be profitable by 2016, the company said,” according to The Journal.

“Philips hasn’t specified the benefits from the deal,” the story notes. Analysts say it “needs about $1 billion in net-present-value from cross-selling products, technology sharing and cost-cutting to meet its (profit) target. That looks a tough ask.”

Either way, the newspaper says, “Philips still has more to do in addressing fundamental problems in its health care business.” And so far, “the vital signs aren’t good.”

The Journal says Philips “derives about 40% of its total revenues and more than half of its operating income from health care. But the industry is suffering from anemic growth. And manufacturing problems in Philips’s Cleveland plant continue to plague the business. Sales are forecast to shrink 1.6% for Philips’s health care business this year, according to analyst consensus, compared with a 0.8% growth rate last year and 6.4% in 2012.”

In addition, the paper reports, “global sales of health care equipment are expected to only marginally improve next year at best, analysts at J.P. Morgan said. Governments in developed markets are reigning in health care costs while growth in emerging markets is slowing.”

 

Wow. Large company with a rough road ahead it seems

 

Eerily quiet out here on the imaging side....too quiet. No direction from the executive management team or even a hint of what's to come next year. Waiting for the next bomb to drop.

 

"Rough road" is an understatement! We just completed a year full of treacherous terrain. Don't think for one minute the competition isn't taking advantage of this unsettled nightmare.

 

from the wsj...

Since Mr. van Houten took the helm in 2011, Philips has been cutting costs and focusing on fewer activities to boost performance. Some analysts argue that if the company fails to further boost performance, the separated businesses could become takeover targets.

Write to Robin van Daalen at Robin.VanDaalen@wsj.com

 

Are these problems unique to different divisions? Which divisions in Philips Healthcare are safe and which ones are hurting?

 

These problems are universal and not exclusive to one division.

 

not remotely correct. US, specifically CV is the cash cow- keeping the lights on in other divisions.

 

...not for long! When the rest goes down the drain it won't matter what CV US has done in the past especially if it's spun off.

 

CV/GI improbable for Spin off.

 

Anyone hear about the new round of lay-offs coming this month?

 

not really, the business has a separate divisional CEO, the old baggage is out the door. writing is on the wall.

 

Why are most of the RIF'd jobs being advertised as open positions ? Something is wrong with this picture.

 

I would like to know is Invivo a good company to sell for? Any info on them??

 

division has managed out the top reps, new reality is $75k -95K income. Good Luck

 

feeling entitled to "info?" Go on and work your ass off like the rest of us and then you'll have a leg to stand on to ask someone WHO KNOWS YOU!